The medical center, which is a regional referral center for hepatitis C, is now a part of the Hepatitis C Therapeutic Registry and Research Network or HCV-TARGET. The network will track thousands of patients over the next five years to monitor the effectiveness and safety of new hepatitis C drugs.
The network is made up of university and community physicians at 103 sites in 31 states, Puerto Rico, Canada and Europe, in partnership with the U.S. Food and Drug Administration.
More Articles on Gastroenterology:
Healthcare Consolidation & the Solo GI Physician: Q&A With Gastroenterologist Dr. Travis Dierenfeldt
ACG, AGA, ASGE: 5 Recent Updates on GI Societies
8 Recent Gastroenterologist Moves & Honors
